LDK378
Ceritinib is an orally available inhibitor of the receptor tyrosine kinase activity of anaplastic lymphoma kinase (ALK) with antineoplastic activity.
Product Specifications
CAS Number
1032900-25-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
558.14
Molecular Formula
C28H36ClN5O3S
Notes
Research use only, not for human use.
Receptor
ALK| FLT3| IGF-1R| Insulin Receptor| STK22D
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS710750-02 5x 0.1 mL
Rabbit anti-human zinc finger protein 35 polyclonal Antibody
Ask
View Details 
M4696-50-01 1 mg
MTOR Inhibitor, Ku-0063794 (rel-5-[2-[ (2R,6S) -2,6-Dimethyl-4-morpholinyl]-4- (4-morpholinyl) pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol) discontinued
Ask
View Details